The successful registration of your medical device relies upon the provision of sufficient clinical evidence that demonstrates its safety and performance. Once in market, the generation of clinical data and its subsequent evaluation is an ongoing process. As such, clinical evaluation and clinical investigations are not just important parts of the initial journey to delivering your device to market, but are also key to keeping it there.
Should you require support in demonstrating or confirming the safety and performance of your device (either pre-market or post-market), our Clinical team offers a variety of services that cover the entire lifecycle of your device.
We offer a smart approach to clinical strategy, providing practical solutions to help you maximise budget and minimise timelines. We are also committed to achieving success for our customers, so our clinical evaluation documentation is consistently comprehensive to facilitate a smooth pathway to device registration.
Every device is different, so whether you require our support with clinical strategy or evaluation, we ensure our approach is tailored to what your project requires. Take a look at our service portfolio below.
Our Clinical Services
Clinical trials and data collection can be extremely costly and time consuming.
Our pragmatic approach to defining your clinical strategy will ensure patient safety whilst minimising time to market – be that in Europe or globally.
Clinical Evaluation MDR 2017/745 Annex XIV
To facilitate the registration of your device, your clinical evaluation needs to be comprehensive.
We can advise on and prepare your Clinical Evaluation Plan (CEP) and Report (CER) and support you with the preparation of your Post Market Clinical Follow-Up (PMCF) plan and PMCF reports. Should it be required, we can also help with your Summary of Safety and Clinical Performance (SSCP) as necessary.
Clinical investigations MDR 2017/745 Annex XV & ISO14155:2020
We can prepare your Clinical Investigation Plan and other essential documents as required for international submission to authorities and ethics committees for first-in-man, feasibility, pivotal or PMCF trials.
Our Clinical team also offers medical writing services that can support the publication of your study results in peer-reviewed journals.
– Co-Founder & CEO
“I found their creative but simple solutions for addressing non-conformity extremely helpful. There was no unnecessary work undertaken – just the provision of straight forward and proactive solutions. I needed matter of fact input; advice and tools that were lean and to the point. And that is exactly what I received. As a result, my understanding is now increased, and compliance has been achieved.”
– Product Management
“Jörg helped us to lay the groundwork for our documentation and organisational structure. Being quality driven and business savvy, he was a reliable source for knowledge and understanding – we always received clear explanations, and I don`t recall a single question he couldn`t answer! His patience and ability to apply give and take helped us to progress in a way that suited our business, and with his methodical and thorough approach he became a driving force toward delivery. Our partnership improved our company`s efficiency and quality – it was the best investment we made last year.”
Co-Founder & Medical Director
“Jörg has supported us in the process of getting our medical products approved. His experience, honesty and reflective thinking helped us to guide us effectively through the process. Jörg’s authentic commitment to customer service has helped to strengthen our working relationship. We see him as a true partner and will continue to work with Congenius.”
Johannes G. Bremmers
Vice President Quality Assurance & Regulatory Affairs
“Jörg and his team have helped us to address several challenges from improving our quality system to re-engineering and validating manufacturing processes and implementing software tools. In these projects Congenius has demonstrated: a broad field of competences, a strong commitment to customer service as well as the ability to apply pragmatic solutions for difficult problems. Their patient but persistent approach is a basis for a pleasant and fruitful relationship. I recommend Congenius as an all-round Quality and Regulatory contractor for the MedTech industry”
Director of Quality
“We managed to improve our Quality Management System with the support of Congenius. Specifically, we have been able to achieve substantial and sustainable progress in our processes and key quality indicators, especially as it relates to our CAPA & Post Market Surveillance areas. In addition to this, Congenius has been of key support in upskilling our employees and ensuring we are internally set up for success going forward. Since we first brought Congenius on board, we have made good strides, which has been noticed both internally and by our regulatory partners.”
Director of Quality
“Having worked with many consulting agencies in the past, the difference with Congenius is clearly in its people who work with passion and a commitment to excellence. I can say without a doubt that my interactions with Congenius personnel have been fantastic, both from a knowledge & skillset standpoint, as well as their integrity & character. It is a pleasure to work with them and we would not be where we are today without their support. I wholeheartedly recommend them to any organisation looking to take their Quality Management System to the next level.”
As a manufacturer of medical products, we depend on a competent partner in the demanding regulatory environment, who can support us promptly and creatively. In Mr. Dogwiler we have not only found the right sparring partner to support us in the creation of our quality management system and a consultant to assist with external audits, but have also learned to appreciate him more and more in the course of working together because of his personality, and his ability to approach things pragmatically. We are looking forward to our further cooperation and can highly recommend Congenius as a reliable partner.
News & Knowledge
MedTech news round up August
Our August MedTech news covers the latest updates, guidance and position papers from the US & Canada, Europe & Switzerland,…
MedTech news round up July
Our July MedTech news covers the latest from the EU commission on harmonised standards under MDR, FDA’s recent efforts to…
Is a decentralized approach the future for clinical trials?
A decentralized clinical trial (DCT) is a trial where subject recruitment, delivery and administration of study medication and collection of…
MedTech news round up June
Our June MedTech news round up includes an update on the EU-Swiss MRA, the latest guidance documents from the FDA…
MedTech news round up May
Our May MedTech news includes timely updates from the US and EU, links to recent notable documents from the MDCG…
MedTech news round up April
Our April MedTech news covers a round up of the latest updates and information from the EU Commission, MDCG, FDA,…
Subscribe to our monthly knowledge update